Trade rationale

Other – Study mentioned in Notes Below

Attached Natcopharm chart showing a decent completion of ABC correction from 975 to 800 levels, which sets for the short term buy call for the Script at 800 levels for the price target of 865, which is the immediate resistance point. 865 target also marks the completion of 38.2% retracement from the previous low of 800 levels.